These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 35183035)
1. Serine proteases in neutrophil extracellular traps exhibit anti-Respiratory Syncytial Virus activity. Lopes BRP; da Silva GS; de Lima Menezes G; de Oliveira J; Watanabe ASA; Porto BN; da Silva RA; Toledo KA Int Immunopharmacol; 2022 May; 106():108573. PubMed ID: 35183035 [TBL] [Abstract][Full Text] [Related]
2. Neutrophil extracellular traps possess anti-human respiratory syncytial virus activity: Possible interaction with the viral F protein. Souza PSS; Barbosa LV; Diniz LFA; da Silva GS; Lopes BRP; Souza PMR; de Araujo GC; Pessoa D; de Oliveira J; Souza FP; Toledo KA Virus Res; 2018 Jun; 251():68-77. PubMed ID: 29621602 [TBL] [Abstract][Full Text] [Related]
3. Effects of neutrophil extracellular traps during human respiratory syncytial virus infection in vitro. Diniz LFA; Matsuba BK; Souza PSS; Lopes BRP; Kubo LH; Oliveira J; Toledo KA Braz J Biol; 2021; 83():e248717. PubMed ID: 34669797 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease. Cortjens B; de Boer OJ; de Jong R; Antonis AF; Sabogal Piñeros YS; Lutter R; van Woensel JB; Bem RA J Pathol; 2016 Feb; 238(3):401-11. PubMed ID: 26468056 [TBL] [Abstract][Full Text] [Related]
5. Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion. Lopes BRP; da Costa MF; Genova Ribeiro A; da Silva TF; Lima CS; Caruso IP; de Araujo GC; Kubo LH; Iacovelli F; Falconi M; Desideri A; de Oliveira J; Regasini LO; de Souza FP; Toledo KA Virus Res; 2020 Jan; 276():197805. PubMed ID: 31712123 [TBL] [Abstract][Full Text] [Related]
6. trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. Oomens AG; Wertz GW J Virol; 2004 Sep; 78(17):9064-72. PubMed ID: 15308702 [TBL] [Abstract][Full Text] [Related]
7. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract. Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148 [TBL] [Abstract][Full Text] [Related]
8. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Feng Yeh C; Wang KC; Chiang LC; Shieh DE; Yen MH; San Chang J J Ethnopharmacol; 2013 Jul; 148(2):466-73. PubMed ID: 23643542 [TBL] [Abstract][Full Text] [Related]
11. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221 [TBL] [Abstract][Full Text] [Related]
12. Human Respiratory Syncytial Virus Infection in a Human T Cell Line Is Hampered at Multiple Steps. de Souza Cardoso R; Viana RMM; Vitti BC; Coelho ACL; de Jesus BLS; de Paula Souza J; Pontelli MC; Murakami T; Ventura AM; Ono A; Arruda E Viruses; 2021 Feb; 13(2):. PubMed ID: 33540662 [TBL] [Abstract][Full Text] [Related]
13. TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection. Pearson H; Todd EJAA; Ahrends M; Hover SE; Whitehouse A; Stacey M; Lippiat JD; Wilkens L; Fieguth HG; Danov O; Hesse C; Barr JN; Mankouri J Thorax; 2021 Jan; 76(1):64-72. PubMed ID: 33109690 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps (NETs) in a randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection. Mutua V; Cavallo F; Gershwin LJ Vet Immunol Immunopathol; 2021 Nov; 241():110323. PubMed ID: 34543829 [TBL] [Abstract][Full Text] [Related]
15. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and molecular characterization of respiratory syncytial viruses at a tertiary care university hospital in Catalonia (Spain) during the 2013-2014 season. Gimferrer L; Campins M; Codina MG; Martín Mdel C; Fuentes F; Esperalba J; Bruguera A; Vilca LM; Armadans L; Pumarola T; Antón A J Clin Virol; 2015 May; 66():27-32. PubMed ID: 25866332 [TBL] [Abstract][Full Text] [Related]
17. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression. Farrag MA; Almajhdi FN Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of the PER.C6 cell line for infection with clinical human respiratory syncytial virus isolates. Houspie L; Keyaerts E; Maes P; Van Ranst M J Virol Methods; 2012 Apr; 181(1):37-42. PubMed ID: 22305961 [TBL] [Abstract][Full Text] [Related]
19. Syncytia Induction by Clinical Isolates of Human Respiratory Syncytial Virus A. Gagliardi TB; Criado MF; Proença-Módena JL; Saranzo AM; Iwamoto MA; de Paula FE; Cardoso RS; Delcaro LS; Silva ML; Câmara AA; Arruda E Intervirology; 2017; 60(1-2):56-60. PubMed ID: 28869960 [TBL] [Abstract][Full Text] [Related]